Literature DB >> 26059395

Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.

Thiago Theodoro Martins Prata1, Camila Mareti Bonin2, Alda Maria Teixeira Ferreira2, Cacilda Tezelli Junqueira Padovani2, Carlos Eurico dos Santos Fernandes2, Ana Paula Machado3, Inês Aparecida Tozetti4.   

Abstract

A specific immune response to human papillomavirus (HPV) in the cervical microenvironment plays a key role in eradicating infection and eliminating mutated cells. However, high-risk HPVs modulate immune cells to create an immunosuppressive microenvironment, and induce these immune cells to produce interleukin 10 (IL-10). This production of IL-10, in conjunction with HPV infection, contributes to the appearance of cervical neoplastic lesions. We sought to characterize the IL-10-producing cellular phenotype, and investigate the influence of host and HPV factors upon the induction of an immunosuppressive microenvironment. Immunohistochemical analysis demonstrated an increase in IL-10 production by keratinocytes, macrophages and Langerhans cells in high-grade cervical lesions and cervical cancer. This increase was more pronounced in patients older than 30 years, and was also correlated with high viral load, and infection with a single HPV type, particularly high-risk HPVs. Our results indicate the existence of a highly immunosuppressive microenvironment composed of different IL-10-producing cellular phenotypes in cervical cancer samples, and samples classified as high-grade cervical lesions (cervical intraepithelial neoplasia stages II and III). The immunosuppressive microenvironment that developed for these different cellular phenotypes favours viral persistence and neoplastic progression.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  human papillomavirus; immunosuppression; interleukin-10

Mesh:

Substances:

Year:  2015        PMID: 26059395      PMCID: PMC4552506          DOI: 10.1111/imm.12487

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

Authors:  Abdelilah Wakkach; Nathalie Fournier; Valérie Brun; Jean-Philippe Breittmayer; Françoise Cottrez; Hervé Groux
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

2.  Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia.

Authors:  Roberto Flores; Mary Papenfuss; Walter T Klimecki; Anna R Giuliano
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

3.  In vitro evidence of the presence of mesenchymal stromal cells in cervical cancer and their role in protecting cancer cells from cytotoxic T cell activity.

Authors:  Juan J Montesinos; María de L Mora-García; Héctor Mayani; Eugenia Flores-Figueroa; Rosario García-Rocha; Guadalupe R Fajardo-Orduña; Marta E Castro-Manrreza; Benny Weiss-Steider; Alberto Monroy-García
Journal:  Stem Cells Dev       Date:  2013-06-14       Impact factor: 3.272

4.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Authors:  Xavier Castellsagué; Mireia Díaz; Silvia de Sanjosé; Nubia Muñoz; Rolando Herrero; Silvia Franceschi; Rosanna W Peeling; Rhoda Ashley; Jennifer S Smith; Peter J F Snijders; Chris J L M Meijer; F Xavier Bosch
Journal:  J Natl Cancer Inst       Date:  2006-03-01       Impact factor: 13.506

Review 5.  The epidemiology of human papillomavirus infections.

Authors:  Janet G Baseman; Laura A Koutsky
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

6.  Distinct T cell subsets and cytokine production in cultures derived from transformation zone and squamous intraepithelial lesion biopsies of the uterine cervix.

Authors:  Nathalie Jacobs; Isabella Renard; Walid Al-Saleh; Pascale Hubert; Jean Doyen; Witold Kedzia; Jacques Boniver; Philippe Delvenne
Journal:  Am J Reprod Immunol       Date:  2003-01       Impact factor: 3.886

7.  Human leukocyte antigen class II and cervical cancer risk: a population-based study.

Authors:  Margaret M Madeleine; Babette Brumback; Kara L Cushing-Haugen; Stephen M Schwartz; Janet R Daling; Anajane G Smith; J Lee Nelson; Peggy Porter; Katherine A Shera; James K McDougall; Denise A Galloway
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

8.  Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix.

Authors:  Raimy Mindiola; Diana Caulejas; José Núñez-Troconis; Mary Araujo; Mariela Delgado; Jesús Mosquera
Journal:  Invest Clin       Date:  2008-12       Impact factor: 0.683

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.

Authors:  Denise Nardelli-Haefliger; Daniel Wirthner; John T Schiller; Douglas R Lowy; Allan Hildesheim; Françoise Ponci; Pierre De Grandi
Journal:  J Natl Cancer Inst       Date:  2003-08-06       Impact factor: 13.506

View more
  19 in total

1.  Association between interleukin-2, interleukin-10, secretory immunoglobulin A and immunoglobulin G expression in vaginal fluid and human papilloma virus outcome in patients with cervical lesions.

Authors:  Jing-Wei Meng; Jing-Hui Song
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

2.  Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.

Authors:  Meghan K Eberhardt; Ashlesha Deshpande; Joseph Fike; Rebecca Short; Kimberli A Schmidt; Shelley A Blozis; Mark R Walter; Peter A Barry
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 3.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

4.  High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women.

Authors:  Emmanouil Papasavvas; Lea F Surrey; Deborah K Glencross; Livio Azzoni; Jocelin Joseph; Tanvier Omar; Michael D Feldman; Anna-Lise Williamson; Maureen Siminya; Avril Swarts; Xiangfan Yin; Qin Liu; Cynthia Firnhaber; Luis J Montaner
Journal:  Oncoimmunology       Date:  2016-01-19       Impact factor: 8.110

5.  Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Joseph G Skeate; Laurie K Rijkee; Julia R Taylor; Heike E Brand; Laila I Muderspach; Lynda D Roman; Annie A Yessaian; Huyen Q Pham; Koji Matsuo; Yvonne G Lin; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Clin Immunol       Date:  2015-09-08       Impact factor: 3.969

Review 6.  Disparity in rates of HPV infection and cervical cancer in underserved US populations.

Authors:  Asok Ranjan Karuri; Vivek Kumar Kashyap; Murali Mohan Yallapu; Nadeem Zafar; Satish K Kedia; Meena Jaggi; Subhash C Chauhan
Journal:  Front Biosci (Schol Ed)       Date:  2017-06-01

Review 7.  Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.

Authors:  Z K Tuong; K Noske; P Kuo; A A Bashaw; S M Teoh; I H Frazer
Journal:  Papillomavirus Res       Date:  2017-10-19

Review 8.  Modulation of antigen presenting cell functions during chronic HPV infection.

Authors:  Abate Assefa Bashaw; Graham R Leggatt; Janin Chandra; Zewen K Tuong; Ian H Frazer
Journal:  Papillomavirus Res       Date:  2017-08-18

9.  Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.

Authors:  Diane M Da Silva; Andrew W Woodham; Paul H Naylor; James E Egan; Neil L Berinstein; W Martin Kast
Journal:  J Interferon Cytokine Res       Date:  2015-12-10       Impact factor: 2.607

10.  Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.

Authors:  Astride Audirac-Chalifour; Kirvis Torres-Poveda; Margarita Bahena-Román; Juan Téllez-Sosa; Jesús Martínez-Barnetche; Bernardo Cortina-Ceballos; Guillermina López-Estrada; Karina Delgado-Romero; Ana I Burguete-García; David Cantú; Alejandro García-Carrancá; Vicente Madrid-Marina
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.